Establishing routine early on helps proactively manage adverse effects associated with CDK4/6 inhibitors, says Kimberly ...

Panelists discuss the critical role of patient education and multidisciplinary coordination in managing immunotherapy side ...

Panelists discuss the importance of vigilant, patient-centered monitoring for metastatic melanoma patients with high disease ...

Paolo Tarantino, MD, PhD, explains that the chemotherapy-related toxicities from an ADC are more likely to limit dosage for ...

The addition of retifanlimab to chemotherapy increased progression-free survival in patients with advanced squamous cell ...

Panelists discuss updated MonumenTAL-1 trial data demonstrating high response rates and prolonged survival with ...

Patients receiving subcutaneous daratumumab have less chair time and premedication than those receiving IV formulation, says ...

While CIML natural killer immunotherapy can result in infection-like reactions, required prior chemo may cause infections, ...

Panelists discuss how a 48-year-old fitness instructor with ALK-rearranged stage IV lung cancer and bone metastases was ...

Panelists discuss treatment considerations for metastatic melanoma with high tumor burden, highlighting the preference for ...

Panelists discuss the growing promise of GPRC5D-targeted therapy in relapsed/refractory multiple myeloma, highlighting ...

This is an actor portrayal of a hypothetical patient profile developed for educational purposes based on characteristics of ...